Skip to content

Clinical trials

Prediabetic State trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prediabetic State Country / region: South Korea Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20111
20132
20141
20151
20161
20181
20191
20202
20222
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status5
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yonsei University3
Kangbuk Samsung Hospital2
Pusan National University Hospital2
Seoul National University Bundang Hospital2
CHEOL WHAN LEE, M.D., Ph.D1
Eli Lilly and Company1
Ewha Womans University1
Jeong-taek Woo1
Korea University Anam Hospital1
Samsung Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prediabetic State16
Diabetes Mellitus6
Diabetes Mellitus, Type 25
Insulin Resistance2
Obesity2
Body Weight1
Coronary Artery Disease1
Glucose Intolerance1
Glucose Metabolism Disorders1
Heart Diseases1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.